Literature DB >> 33868668

Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?

Somaya Albhaisi1, Arun J Sanyal2.   

Abstract

Entities:  

Year:  2021        PMID： 33868668      PMCID： PMC8043706          DOI： 10.1002/cld.1029

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  47 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 2.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

Review 3.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

4.  Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.

Authors:  J S Ahn; D H Sinn; Y W Min; S N Hong; H S Kim; S-H Jung; S Gu; P-L Rhee; S W Paik; H J Son; G-Y Gwak
Journal:  Aliment Pharmacol Ther       Date:  2016-11-18       Impact factor: 8.171

Review 5.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

6.  A case-control study of non-alcoholic fatty liver disease in breast cancer.

Authors:  Ahmet Bilici; Mustafa Ozguroglu; Ismail Mihmanli; Hande Turna; Ibrahim Adaletli
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

7.  Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women.

Authors:  Min-Sun Kwak; Jeong Yoon Yim; Ann Yi; Goh-Eun Chung; Jong In Yang; Donghee Kim; Joo Sung Kim; Dong-Young Noh
Journal:  Dig Liver Dis       Date:  2019-01-09       Impact factor: 4.088

8.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

9.  Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

Authors:  Matthew J Armstrong; Diarmaid D Houlihan; Louise Bentham; Jean C Shaw; Robert Cramb; Simon Olliff; Paramjit S Gill; James M Neuberger; Richard J Lilford; Philip N Newsome
Journal:  J Hepatol       Date:  2011-05-18       Impact factor: 25.083

10.  Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).

Authors:  Tobias Pischon; Petra H Lahmann; Heiner Boeing; Christine Friedenreich; Teresa Norat; Anne Tjønneland; Jytte Halkjaer; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Gregory Guernec; Manuela M Bergmann; Jakob Linseisen; Nikolaus Becker; Antonia Trichopoulou; Dimitrios Trichopoulos; Sabina Sieri; Domenico Palli; Rosario Tumino; Paolo Vineis; Salvatore Panico; Petra H M Peeters; H Bas Bueno-de-Mesquita; Hendriek C Boshuizen; Bethany Van Guelpen; Richard Palmqvist; Göran Berglund; Carlos Alberto Gonzalez; Miren Dorronsoro; Aurelio Barricarte; Carmen Navarro; Carmen Martinez; J Ramón Quirós; Andrew Roddam; Naomi Allen; Sheila Bingham; Kay-Tee Khaw; Pietro Ferrari; Rudolf Kaaks; Nadia Slimani; Elio Riboli
Journal:  J Natl Cancer Inst       Date:  2006-07-05       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.